Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 202 participants.
Also called NCT07083765
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 202 participants
- Sponsor
- Registry
-
NCT07083765
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07083765. Randomized; triple masking; primary purpose treatment. Start 2026-10 (anticipated); primary completion 2028-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
- Acronym
- RADAR
- Condition
- Hypertension
- Condition
- Hypertension,Essential
- Intervention (Drug)
- Dehydrated Alcohol Injection, USP
- Intervention (Procedure)
- Sham procedure
- Lead sponsor
- Ablative Solutions, Inc.
Record details
- Record id
cardio:ct-nct07083765- Content hash
4abd69015b40d4e2809af227ce56e6b60f4716a36d71790d69bcdb47724028f5